Pediatric Pain Rehabilitation Program

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of this study is to describe the demographic, medical, and psychological/behavioral characteristics of children and adolescent patients admitted to the Cleveland Clinic Children's Hospital's Pain Rehabilitation Program. The data will also be used to evaluate the clinical outcomes of patients admitted to the program as well as to examine the impact of various background factors on clinical outcomes.

See also
Status	Clinical Trial	Phase
Completed	`NCT00885976` - The Predictors and Patient Versus Parental Perceptions of Health-Related Quality of Life in Pediatric Chronic Pain	N/A
Active, not recruiting	`NCT04331236` - Yoga-CBT Group Intervention for Adolescents With Chronic Pain and Their Caregivers	N/A
Enrolling by invitation	`NCT05239299` - Treatment Options for Pediatric Chronic Pain: How do we Best Disseminate Our Scientific Findings

NCT number	NCT01340261
Study type	Observational
Source	The Cleveland Clinic
Contact
Status	Completed
Phase
Start date	March 2007
Completion date	March 31, 2021

Pediatric Pain Rehabilitation Program

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms